Product: Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.
Reason for recall: Cross Contamination with Other Products
Recall initiated: 20240409
Status: Ongoing
Classification: Class III
Recall type: Voluntary: Firm initiated